In addition to hyperphagia, the association of other obesity- and BBS-related comorbidities, such as liver steatosis, glucose intolerance, dyslipidemia, and albuminuria, with caregiver and patient burden should be assessed in future studies to determine the best course of treatment. This evidence concerns the gene BBS2 and Obesity.